Categories : Endocrine & Metabolic
Product Packaging : 10 / 30 tablets
Product Composition : 50 mg, 100 mg
Send MessageSitagliptin Tablets are oral antidiabetic medications belonging to the DPP-4 (dipeptidyl peptidase-4) inhibitor class, designed to improve glycemic control in patients with type 2 diabetes mellitus. Sitagliptin acts by preventing the degradation of incretin hormones such as GLP-1 and GIP, thereby enhancing glucose-dependent insulin secretion and suppressing glucagon release from the pancreas.
This mechanism enables effective reduction of blood glucose levels without causing significant hypoglycemia, making it a preferred option in modern diabetes therapy. Sitagliptin is often prescribed as monotherapy or in combination with other antidiabetic agents for comprehensive metabolic control.
Genliva Wellness LLP, Himatnagar, India, is a trusted sitagliptin tablet manufacturer India, offering high-quality DPP-4 inhibitor formulations for domestic distribution as well as global pharmaceutical export and contract manufacturing services.
Sitagliptin Tablets are DPP-4 inhibitor antidiabetic medications used to improve blood glucose control in patients with type 2 diabetes mellitus. They work by enhancing incretin hormone activity, which helps regulate insulin release and reduce excess glucose production.
These tablets are commonly prescribed for the management of type 2 diabetes mellitus along with diet and exercise. They help maintain stable blood sugar levels and improve overall glycemic control.
Sitagliptin Tablets provide effective glucose regulation with low hypoglycemia risk and convenient daily dosing for improved diabetic management.
